Maxlinear (MXL) Research & Development (2010 - 2026)

Maxlinear (MXL) has reported Research & Development for 17 consecutive years, with $56.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 18.72% year-over-year to $56.0 million in Q2 2026; TTM through Jun 2026 was $215.1 million, a 4.16% increase from a year earlier, with the FY2025 full-year figure at $208.6 million, down 7.37% from the prior year.
• Research & Development was $56.0 million for Q2 2026 at Maxlinear, up from $53.2 million in the prior quarter.
• Over five years, Research & Development peaked at $80.4 million in Q2 2022 and troughed at $47.2 million in Q2 2025.
• A 5-year average of $61.6 million and a median of $60.7 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development dropped 21.41% in 2024 and increased 18.72% in 2026, its largest moves.
• Over 5 years, Research & Development stood at $73.7 million in 2022, then decreased by 11.49% to $65.2 million in 2023, then retreated by 21.41% to $51.3 million in 2024, then gained by 0.81% to $51.7 million in 2025, then increased by 8.4% to $56.0 million in 2026.
• The last three Research & Development figures came in at $56.0 million (Q2 2026), $53.2 million (Q1 2026), and $51.7 million (Q4 2025), per Business Quant data.